Shveta Suresh Motwani, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cisplatin | 8 | 2024 | 1645 | 2.800 |
Why?
|
Acute Kidney Injury | 14 | 2024 | 1926 | 2.510 |
Why?
|
Antiemetics | 1 | 2024 | 187 | 0.830 |
Why?
|
Paraproteins | 1 | 2016 | 38 | 0.550 |
Why?
|
Fluid Shifts | 5 | 2014 | 20 | 0.470 |
Why?
|
Glomerular Filtration Rate | 4 | 2024 | 2154 | 0.460 |
Why?
|
Kidney Glomerulus | 1 | 2016 | 568 | 0.460 |
Why?
|
Paraproteinemias | 1 | 2016 | 246 | 0.450 |
Why?
|
Kidney Diseases | 3 | 2020 | 2083 | 0.400 |
Why?
|
Airway Resistance | 4 | 2014 | 400 | 0.340 |
Why?
|
Amyloidosis | 1 | 2016 | 817 | 0.330 |
Why?
|
Antineoplastic Agents | 6 | 2024 | 13591 | 0.320 |
Why?
|
Creatinine | 3 | 2024 | 1892 | 0.320 |
Why?
|
Ascites | 2 | 2020 | 338 | 0.310 |
Why?
|
Hyponatremia | 2 | 2020 | 279 | 0.290 |
Why?
|
Neoplasms | 7 | 2024 | 22030 | 0.250 |
Why?
|
Sleep Apnea, Obstructive | 5 | 2014 | 1852 | 0.220 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2024 | 2239 | 0.210 |
Why?
|
Cystatin C | 1 | 2024 | 270 | 0.210 |
Why?
|
Kidney | 4 | 2023 | 7016 | 0.190 |
Why?
|
Kidney Tubules | 1 | 2023 | 449 | 0.190 |
Why?
|
Vomiting | 1 | 2024 | 651 | 0.180 |
Why?
|
Pharynx | 2 | 2013 | 432 | 0.180 |
Why?
|
Immunoglobulin Light Chains | 2 | 2020 | 286 | 0.170 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2020 | 109 | 0.160 |
Why?
|
Kidney Function Tests | 1 | 2020 | 677 | 0.160 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 428 | 0.150 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 2016 | 40 | 0.140 |
Why?
|
Cryoglobulinemia | 1 | 2016 | 84 | 0.130 |
Why?
|
Sleep Apnea Syndromes | 2 | 2016 | 973 | 0.130 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2016 | 88 | 0.130 |
Why?
|
Pleural Neoplasms | 1 | 2020 | 609 | 0.120 |
Why?
|
Thrombotic Microangiopathies | 1 | 2016 | 123 | 0.120 |
Why?
|
Drainage | 1 | 2020 | 1161 | 0.120 |
Why?
|
Glomerulonephritis | 1 | 2016 | 337 | 0.120 |
Why?
|
Sodium | 1 | 2020 | 1588 | 0.120 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2016 | 649 | 0.110 |
Why?
|
Body Water | 1 | 2014 | 341 | 0.110 |
Why?
|
Leg | 3 | 2014 | 1087 | 0.110 |
Why?
|
Immunomodulation | 1 | 2016 | 545 | 0.100 |
Why?
|
Oxidative Stress | 1 | 2023 | 3100 | 0.100 |
Why?
|
Sleep Apnea, Central | 1 | 2013 | 88 | 0.100 |
Why?
|
Stem Cell Transplantation | 1 | 2020 | 1599 | 0.100 |
Why?
|
Respiratory System | 1 | 2014 | 557 | 0.090 |
Why?
|
Humans | 27 | 2024 | 758381 | 0.090 |
Why?
|
Body Fluids | 1 | 2012 | 319 | 0.090 |
Why?
|
Pressure | 1 | 2013 | 1155 | 0.090 |
Why?
|
Neck | 2 | 2012 | 731 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1454 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1402 | 0.080 |
Why?
|
Kidney Failure, Chronic | 2 | 2012 | 2457 | 0.080 |
Why?
|
Renal Dialysis | 3 | 2016 | 1786 | 0.080 |
Why?
|
Polysomnography | 5 | 2014 | 1825 | 0.080 |
Why?
|
Middle Aged | 15 | 2024 | 219560 | 0.080 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2021 | 2276 | 0.080 |
Why?
|
Carbon Dioxide | 1 | 2013 | 1146 | 0.080 |
Why?
|
Edema | 1 | 2012 | 768 | 0.080 |
Why?
|
Apoptosis | 1 | 2023 | 9468 | 0.070 |
Why?
|
Water | 1 | 2012 | 1402 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3217 | 0.070 |
Why?
|
Immunotherapy | 1 | 2021 | 4641 | 0.060 |
Why?
|
Risk | 1 | 2018 | 9599 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4312 | 0.060 |
Why?
|
Aged | 11 | 2023 | 168217 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4540 | 0.060 |
Why?
|
Logistic Models | 1 | 2018 | 13276 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5129 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2012 | 2567 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2024 | 80170 | 0.040 |
Why?
|
Nephrology | 1 | 2024 | 263 | 0.040 |
Why?
|
Blood Pressure | 1 | 2016 | 8453 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9160 | 0.040 |
Why?
|
Adult | 9 | 2024 | 219916 | 0.040 |
Why?
|
Electric Impedance | 2 | 2014 | 754 | 0.040 |
Why?
|
Male | 15 | 2023 | 358742 | 0.040 |
Why?
|
Prognosis | 5 | 2020 | 29558 | 0.040 |
Why?
|
Water-Electrolyte Balance | 1 | 2020 | 325 | 0.040 |
Why?
|
Risk Factors | 6 | 2024 | 73806 | 0.040 |
Why?
|
Nephritis, Interstitial | 1 | 2020 | 154 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58681 | 0.040 |
Why?
|
Heart Failure | 2 | 2013 | 11594 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8530 | 0.040 |
Why?
|
Cross-Over Studies | 2 | 2014 | 2048 | 0.040 |
Why?
|
Female | 13 | 2023 | 390316 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 2020 | 416 | 0.030 |
Why?
|
Hypertension | 1 | 2016 | 8503 | 0.030 |
Why?
|
Gravity Suits | 1 | 2014 | 12 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2114 | 0.030 |
Why?
|
Cohort Studies | 3 | 2024 | 41252 | 0.030 |
Why?
|
Young Adult | 2 | 2018 | 58808 | 0.030 |
Why?
|
Jugular Veins | 1 | 2014 | 210 | 0.030 |
Why?
|
Pneumonectomy | 1 | 2020 | 1111 | 0.030 |
Why?
|
Partial Pressure | 1 | 2013 | 245 | 0.030 |
Why?
|
Adolescent | 2 | 2018 | 87888 | 0.020 |
Why?
|
Child | 1 | 2020 | 79813 | 0.020 |
Why?
|
Ontario | 1 | 2012 | 397 | 0.020 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2016 | 574 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2014 | 12262 | 0.020 |
Why?
|
Contrast Media | 1 | 2023 | 5298 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39060 | 0.020 |
Why?
|
Respiration | 1 | 2016 | 1654 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2850 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9650 | 0.020 |
Why?
|
Risk Assessment | 2 | 2024 | 23883 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9304 | 0.020 |
Why?
|
Posture | 1 | 2011 | 953 | 0.020 |
Why?
|
Wakefulness | 1 | 2013 | 1256 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6439 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20500 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12721 | 0.020 |
Why?
|
Lower Extremity | 1 | 2012 | 1188 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21273 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5861 | 0.010 |
Why?
|
Sleep | 1 | 2016 | 4745 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11709 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15646 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12096 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10505 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2014 | 36285 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15785 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 39873 | 0.010 |
Why?
|
Prospective Studies | 1 | 2012 | 54136 | 0.000 |
Why?
|
Animals | 1 | 2016 | 167777 | 0.000 |
Why?
|